About
Our Mission
Leadership
Partners
Our Technologies
TALEN® Technology
Gene Editing
PulseAgile Technology
Patents
Pipeline
Products
Clinical Indications
Manufacturing
Investors
Press Releases
Corporate presentation & ESG report
Scientific Presentations
Scientific Publications
Events and Webcasts
2021 Cellectis Innovation Days
Stock Information
Corporate Governance
Governance Documents
Board of Directors & Committee Members
Shareholders Meeting
SEC Filings
Contact
IR Inquiries
Email Alerts
Investor FAQ
Careers
Our Culture
Job Opportunities
Contact us
fr
Press Releases
Our latest news and press releases
Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All
2025
2024
2023
2022
2021
2020
26
Jun 2025
16:30 E.S.T.
Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025
Read more
21
May 2025
16:30 E.S.T.
Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025
Read more
12
May 2025
16:30 E.S.T.
Cellectis Reports Financial Results for the First Quarter 2025
Read more
06
May 2025
16:30 E.S.T.
Cellectis to Report First Quarter Financial Results on May 12, 2025
Read more
28
Apr 2025
16:30 E.S.T.
Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting
Read more
13
Mar 2025
18:15 E.S.T.
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update
Read more
1
2
3
Next